-
341
Effect of Recombinant Human Epidermal Growth Factor Associated with Conventional Drug Therapy on the Dry Eye Symptom Score in Patients with Dry Eyes after Cataract Surgery: A Systematic Review and Meta-Analysis
Published 2022-01-01“…This study aimed to systematically assess the effect of recombinant human epidermal growth factor (rhEGF) associated with conventional drugs on the score of dry eye symptoms in patients with dry eyes after cataract surgery. …”
Get full text
Article -
342
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
Published 2019-03-01Subjects: Get full text
Article -
343
Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study
Published 2025-01-01“…Yujing Tan,1,* Hanfang Jiang,2,* Xinzhu Tian,1,* Fei Ma,1 Jiayu Wang,1 Pin Zhang,1 Binghe Xu,1 Ying Fan,1 Weihong Zhao3 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, People’s Republic of China; 2Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, People’s Republic of China; 3Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ying Fan; Weihong Zhao, Email fanying@cicams.ac.cn; zhaowh0818@163.comPurpose: This study aims to explore the role of the non-luminal disease score (NOLUS) for everolimus in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC).Methods: NOLUS has previously been established as an algorithm: NOLUS (0– 100) = − 0.45 × ER(%) − 0.28 × PR(%) + 0.27 × Ki67(%) + 73. …”
Get full text
Article -
344
-
345
Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China
Published 2024-11-01Subjects: “…|urothelial carcinoma|human epidermal growth factor receptor 2|clinicopathological characteristics|china…”
Get full text
Article -
346
-
347
Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly
Published 2025-01-01Subjects: Get full text
Article -
348
D-tryptophan triggered epithelial-mesenchymal transition by activating TGF-β signaling pathway
Published 2022-09-01Subjects: Get full text
Article -
349
Immunotherapy versus targeted therapy in management of recurrent squamous cell carcinoma of oral tongue
Published 2024-06-01Subjects: “…Vascular endothelial growth factor…”
Get full text
Article -
350
A novel TGFBR2 mutation causes Loeys-Dietz syndrome in a Chinese infant: A case report
Published 2025-01-01Subjects: Get full text
Article -
351
Effect of Exercise Preconditioning on Protein Expression of VEGF and NeuN in Rats with Cerebral Ischemia-reperfusion
Published 2021-02-01Subjects: “…vascular endothelial growth factor…”
Get full text
Article -
352
Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer: Analysis from EVEREXES Taiwan Subset
Published 2023-07-01Subjects: “…hormone receptor-positive human epidermal growth factor receptor 2-negative advanced breast cancer…”
Get full text
Article -
353
Biomaterial-based strategies: a new era in spinal cord injury treatment
Published 2025-12-01Subjects: Get full text
Article -
354
Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2
Published 2016-01-01“…However, the role of S1PR2 ligation in proangiogenic vascular endothelial growth factor- (VEGF-) A and matrix metalloproteinase- (MMP-) 2 release from MC is unknown. …”
Get full text
Article -
355
Specific Features of Vascular Endothelium in Patients with Severe Forms of Inflammatory Bowel Diseases
Published 2018-11-01Subjects: “…vascular endothelial growth factor…”
Get full text
Article -
356
Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method
Published 2021-09-01Subjects: Get full text
Article -
357
-
358
Risk Stratification and Adjuvant Chemotherapy for High‐Risk Stage IA Lung Adenocarcinoma: The Unmet Needs
Published 2025-01-01Subjects: Get full text
Article -
359
The mitigating effect of a topical preparation of amlodipine on imiquimod-induced psoriasis-like lesion in mice Authors
Published 2024-12-01Subjects: “…vascular endothelial growth factor…”
Get full text
Article -
360
Irisin Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis in Bile Duct Ligation Mice Model and Improves Mitochondrial Dysfunction
Published 2024-12-01Subjects: Get full text
Article